| (Values in U.S. Thousands) | Jun, 2023 | Jun, 2022 | Jun, 2021 | Jun, 2020 | Jun, 2019 |
| Sales | 0 | 30 | 84 | 3 | 0 |
| Sales Growth | unch | -64.81% | +2,537.17% | unch | unch |
| Net Income | -1,045 | -26,358 | -8,641 | -7,076 | -7,649 |
| Net Income Growth | +96.03% | -205.02% | -22.12% | +7.49% | +0.25% |
Auscann Group Holdings Ltd (AC8.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
AusCann Group Holdings Ltd produces medicinal cannabis. It delivers high-quality, economical, and clinically validated cannabinoid medicinal products.
Fiscal Year End Date: 06/30